Hormonal Architecture

BPA, phthalates and parabens occupy estrogen receptors (ERα/ERβ) and disrupt normal signaling, regardless of whether the compound itself has already been cleared from the body. DIM (diindolylmethane) is an AhR ligand that induces the liver enzymes CYP1A1/CYP1A2, shifting estrogen metabolism from the proliferative 16α-hydroxyestrone pathway toward the protective 2-hydroxyestrone pathway — confirmed in a human RCT using transdermal estradiol. Calcium-D-Glucarate works further downstream, in the gut: it inhibits β-glucuronidase, the bacterial enzyme that would otherwise deconjugate and re-release already-cleared hormones and xeno-estrogens back into circulation (enterohepatic recirculation). Human data show up to 57% inhibition of that enzyme's activity.

Nettle root lignans block the binding of SHBG (sex hormone-binding globulin) to its membrane receptor — a direct, specifically confirmed finding (Hryb et al. 1995), originally demonstrated for prostatic tissue but relevant to SHBG's role systemically in both sexes. Nettle root's separately-claimed aromatase and 5-alpha-reductase inhibition is weak and inconsistently confirmed across studies — that is not why this herb is in the protocol; the SHBG finding is.

Tongkat Ali's eurycomanone inhibits SHBG's binding to testosterone specifically, freeing more testosterone into bioavailable circulation, and lowers cortisol in several trials — the strongest human evidence in this entire protocol, backed by a meta-analysis and a separate trial in women. Saw Palmetto works on a different axis: it inhibits 5-alpha-reductase specifically in prostatic tissue, reducing DHT formation there without lowering systemic testosterone — but only when paired with Nettle root. The two most rigorous RCTs ever run on Saw Palmetto alone (Bent et al. 2006, NEJM; CAMUS/Barry et al. 2011, JAMA, up to 3× standard dose) found no benefit over placebo, and the 2023 Cochrane review (27 trials) confirms it: alone, it doesn't help. The standardized Saw Palmetto + Nettle root combination has its own positive 24-week RCT. If prostate/urinary symptoms are the reason you're here rather than the androgen axis in general, see the GATE protocol, which is built specifically around that combination. Suma is included as a secondary, optional herb only — evidence for its testosterone effect conflicts directly between species (a mouse study shows an increase; a rat study shows none), so it is not treated as a primary herb here.

Vitex agnus-castus acts on dopamine D2 receptors in the pituitary, lowering elevated prolactin — a meta-analysis confirms real benefit over placebo for PMS specifically (this use is separate from Vitex's luteal-phase/progesterone role in fertility support, which belongs to the Fertility Protocol, not here). Black Cohosh is not a phytoestrogen — that older assumption was directly refuted in an ovariectomized rat model showing no estrogenic effect on uterine tissue. It instead works through serotonin receptors (5-HT1A, 5-HT1D, 5-HT7), which is mechanistically relevant to hypothalamic hot-flash regulation. Sage has one of the strongest single results in this protocol: a Swiss multicenter RCT found a 50% reduction in hot flash intensity at 4 weeks, rising to 64% at 8 weeks.

Fenugreek has been used for exactly these two purposes for roughly 3,500 years — the Ebers Papyrus records it for menstrual pain and for lactation support. For women, a direct RCT shows significant pain reduction in dysmenorrhea, and its phytoestrogenic activity has shown benefit for postmenopausal vasomotor symptoms. For men, the evidence is more mixed: a more recent, more rigorous trial found salivary testosterone rose significantly vs. placebo at the highest dose, but plasma total/free testosterone rose only vs. baseline, not vs. placebo — an older, less rigorous trial reported a clearer result. Include it for the well-established female indications with confidence; treat the male testosterone claim as plausible but not settled.